This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB08576/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08576/identifier/chemspider/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08576/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08576/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08576/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08576
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08576 n8:DB08576
dcterms:title
1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE
adms:identifier
n10:6852124 n11:99445047 n12:DB08576 n13:STX n14:5254581
n3:IUPAC-Name
n4:271B3E7A-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3E80-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3E7F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3E7C-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3E7D-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3E7E-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3E78-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3E79-363D-11E5-9242-09173F13E4C5 n4:271B3E76-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3E77-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3E86-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3E87-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3E81-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3E82-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3E84-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3E83-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3E85-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3E8C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3E8E-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3E8F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3E8B-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3E8A-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3E8D-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3E7B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3E88-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3E89-363D-11E5-9242-09173F13E4C5